Sanjay Sridaran

ORCID: 0000-0003-0769-9099
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Corneal Surgery and Treatments
  • Osteoarthritis Treatment and Mechanisms
  • Streptococcal Infections and Treatments
  • Knee injuries and reconstruction techniques
  • Bacterial Identification and Susceptibility Testing
  • Mesenchymal stem cell research
  • Antimicrobial Resistance in Staphylococcus

Georgia Institute of Technology
2014-2023

The Wallace H. Coulter Department of Biomedical Engineering
2014-2023

University of Pittsburgh Medical Center
2021

Abstract Introduction Micronized dehydrated human amnion/chorion membrane (μ-dHACM) is derived from donated placentae and has anti-inflammatory, low immunogenic anti-fibrotic properties. The objective of this study was to quantitatively assess the efficacy μ-dHACM as a disease modifying intervention in rat model osteoarthritis (OA). It hypothesized that intra-articular injection would attenuate OA progression. Methods Lewis rats underwent medial meniscal transection (MMT) surgery induce OA....

10.1186/ar4476 article EN cc-by Arthritis Research & Therapy 2014-02-06

Bloodstream infections caused by MSSA are associated with significant morbidity and mortality. Traditional treatment of bacteraemia includes an IV antistaphylococcal β-lactam surgical source control when indicated.To evaluate the time to blood culture clearance as well in-hospital 90 day mortality in patients persistent treated combination penicillin plus carbapenem therapy.Consecutive therapy were identified study investigators reviewed independent clinicians. The decision initiate was made...

10.1093/jacamr/dlab148 article EN cc-by-nc JAC-Antimicrobial Resistance 2021-07-12

Background: Micronized dehydrated human amnion/chorion membrane (mdHACM) has reduced short term post-traumatic osteoarthritis (PTOA) progression in rats when delivered 24 h after medial meniscal transection (MMT) and is being investigated for clinical use as a disease modifying therapy. Much remains to be assessed, including its potential longer-term therapeutic benefit treatment effects onset of joint degeneration. Objectives: Characterize acute with mdHACM determine whether administered...

10.3389/fbioe.2023.1224141 article EN cc-by Frontiers in Bioengineering and Biotechnology 2023-09-06
Coming Soon ...